Neuroprotection for Parkinson's disease: a call for clinically driven experimental design
Lancet Neurol
.
2003 Jul;2(7):393.
doi: 10.1016/s1474-4422(03)00432-0.
Author
Erwan Bezard
1
Affiliation
1
Basal Gang, Laboratoire de Neurophysiologie, CNRS UMR 5543, Université Victor Segalen, 33076, Bordeaux, France. erwan.bezard@umr5543.u-bordeaux2.fr <erwan.bezard@umr5543.u-bordeaux2.fr>
PMID:
12849115
DOI:
10.1016/s1474-4422(03)00432-0
No abstract available
MeSH terms
Animals
Humans
Models, Animal
Neuroprotective Agents / therapeutic use*
Parkinson Disease / drug therapy*
Research Design / standards*
Substances
Neuroprotective Agents